Medical disclaimer
This article is for general education and is not medical advice. It is not a substitute for evaluation, diagnosis, or treatment by a licensed clinician. Talk with a qualified clinician about your individual situation.
Compounded medications
Harbor is a technology platform. Medical evaluations are conducted by independent, licensed healthcare providers who decide whether treatment is appropriate. Compounded medications are prepared by licensed U.S. pharmacies for individual patients and are not reviewed by the FDA for safety or effectiveness.
Sources
- National Center for Complementary and Integrative Health. Diabetes and dietary supplements: what you need to know (updated November 2023).
- National Center for Complementary and Integrative Health. Goldenseal (updated February 2025).
- U.S. Food and Drug Administration. Questions and answers on dietary supplements (content current as of August 27, 2026).
- Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045.
- Asbaghi O, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2020;38:43-49.
- Elahi Vahed I, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026;50:53-73.
- Xiong P, et al. The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials. Complement Ther Clin Pract. 2020;39:101113.
- Amini MR, et al. Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;49:102337.
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57:712-717.
- Danoun S, et al. Quality evaluation of berberine food supplements with high-field and compact (1)H NMR spectrometers. J Pharm Biomed Anal. 2023;223:115161.
- Dumitru CN, et al. Berberine-drug interactions: mechanisms, clinical relevance and risk stratification. Pharmaceuticals. 2026;19:1313.
- Guo Y, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68:213-217.
- DailyMed. Ozempic (semaglutide) injection, prescribing information (June 2026).
- DailyMed. Wegovy (semaglutide) injection and tablets, prescribing information (June 2026).
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002.









